Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for November 2003
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Trials agency to spearhead bioscience drive
UK aiming to become biosciences world leader..(more)

 Red Door's hepatitis campaign wins top PR prize
Red Door scoops prestigious PR award..(more)

 FDA claims victory after medicines importer shutdown
FDA cracks down on Canadian prescription medicine importers..(more)

 Pipeline promises $10 billion says Novartis
Novartis focuses R&D budget on developing cancer treatments..(more)

 Finances threaten Cambridge neuroscience centre
Finances threaten Cambridge neuroscience centre..(more)

 Government and pharma strike new NRT 'kickback' deal
Government and pharma strike new 'kickback' deal on smoking ..(more)

 Government backs over the counter Zocor
Government wants statins to be available to consumers..(more)

 GlaxoSmithKline gains COPD licence in US
GlaxoSmithKline gains COPD licence in US..(more)

 Wanted: nurse entrepreneurs
Nurses' clinical roles extended..(more)

 Foundation plans narrowly escape defeat
Labour MPs and doctors criticise plans..(more)

 Antisoma to launch cancer treatment by 2005
Candidate enters phase III trials..(more)

 Compromise reached on Medicare reform
Compromise reached on Medicare reform..(more)

 Merck drops depression drug
Potential blockbuster depression drug dropped..(more)

 Pfizer poised to exit Celltech deal
Pfizer poised to exit Celltech deal..(more)

 Breakthrough offers hope of diabetes cure
Breakthrough offers hope of diabetes cure..(more)

 NHS in Wales given £25m extra to improve services
Extra money on health and socal care in Wales..(more)

 Limited NICE recommendation for newer epilepsy treatments
Limited NICE recommendation for newer epilepsy treatments..(more)

 Pfizer submits blockbuster follow up to Neurontin
Pfizer submits blockbuster follow up to Neurontin..(more)

 GlaxoSmithKline to open biotech research centre
GlaxoSmithKline to open biotech research centre..(more)

 Slimmed down Bayer rules out merger
Slimmed down Bayer rules out merger..(more)

 NHS launches 'one-stop' website
NHS launches 'one-stop' website..(more)

 Lords reject 'shambolic' foundation plans
'Shambolic' foundation plans face Lords scrutiny..(more)

 'European FDA' one step closer
'European FDA' one step closer..(more)

 NHS gears up for out of hours revolution
NHS gears up for out of hours revolution..(more)

 Lilly resolves FDA manufacturing dispute
Lilly resolves FDA manufacturing dispute..(more)

 Teva stretches lead in generics
Teva stretches lead in generics..(more)

 GSK looks to consolidate UK lead with Avandamet
GSK looks to consolidate UK lead with Avandamet..(more)

 OTC omeprazole to become Glaxo's next generation Zantac
OTC omeprazole to become Glaxo's next generation Zantac..(more)

 Roche survey shows cancer postcode prescribing continues
Roche survey shows cancer postcode prescribing continues..(more)

 GlaxoSmithKline announce Indian partnership
GlaxoSmithKline announce Indian partnership..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.